Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05421741 · ClinicalTrials.gov registry record · Phase 4

Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

A Phase 4 study of Tibial Fractures and Osteomyelitis Tibia, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
Phase 4
Development phase
484
Enrollment target
14
Study locations

NCT05421741: Recruiting Phase 4 study of Tibial Fractures and Osteomyelitis Tibia, sponsored by Wake Forest University Health Sciences.

NCT05421741 is a Phase 4 study of Tibial Fractures and Osteomyelitis Tibia that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 484 participants, above the 300-participant average among 12 other Tibial Fractures trials with a reported enrollment target (61% higher). The trial reports 14 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05421741, a Phase 4 study of Tibial Fractures and Osteomyelitis Tibia, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
Phase 4
Development phase
484 participants
Enrollment target
14
Study locations

Study Summary

This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intramedullary (IM) nailing.

Primary Outcome

Number of participants in each group who develop SSI as defined by the criteria establish by the Centers for Disease Control and Prevention (CDC). The CDC criteria define deep as occurring within 30 or 90 days after the procedure. However, we will continue to follow patients for 12 months and document any infections and other complications during this period.

Interventions

  • DRUG Antibiotic coated intramedullary Nail
  • OTHER Standard Intramedullary Nail

Study Locations (14)

North Carolina

  • University of North Carolina Chapel Hill - Chapel Hill
  • Atrium Health Carolinas Medical Center - Charlotte
  • Atrium Health Cabarrus - Concord
  • Atrium Health Wake Forest Baptist - Winston-Salem

Florida

  • University of Florida Gainesville - Gainesville
  • Florida Orthopaedic Institute - Temple Terrace

Texas

  • University of Texas Houston - Houston
  • San Antonio Military Medical Center - San Antonio

Virginia

  • Carilion Clinic - Roanoke
  • Valley Health System - Winchester

Georgia

  • Atrium Health Navicent - Macon

Kentucky

  • University of Kentucky - Lexington

Pennsylvania

  • Penn State Milton S. Hershey Medical Center - Hershey

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 484 participants
Start Date 2023-05-15
Est. Completion 2027-12
Phase Phase 4
Wake Forest University Health Sciences

1,140 total trials

What NCT05421741 shows while recruiting

NCT05421741 is an interventional study that assigns participants to a tested intervention. The registered 484 participants enrollment target is mid-sized for trials with a published cap, above the 300-participant average among 12 other Tibial Fractures trials with a reported enrollment target (61% higher).

The record links to 3 conditions, with Tibial Fractures appearing as the primary indexed condition, and to 2 interventions - of which Antibiotic coated intramedullary Nail is the first listed.

NCT05421741 lists 14 locations in 8 states (North Carolina, Florida, Texas).

Frequently Asked Questions

What is clinical trial NCT05421741 about?

NCT05421741 is a clinical study titled "Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial". This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intramedullary (IM) nailing.

What is the current status of trial NCT05421741?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 484 participants. The study started on 2023-05-15. Estimated completion is 2027-12.

What conditions does trial NCT05421741 study?

This clinical trial studies the following conditions: Tibial Fractures, Osteomyelitis Tibia, Open Tibia Fracture.

What interventions are being tested in trial NCT05421741?

The interventions under investigation include: Antibiotic coated intramedullary Nail (DRUG), Standard Intramedullary Nail (OTHER).

Who is sponsoring clinical trial NCT05421741?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05421741 being conducted?

This trial has 14 study locations across Florida, Georgia, Kentucky, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tibial Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05421741's enrollment target sits among peer trials

484 4th of 12 higher than 9 of 12 other Tibial Fractures trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tibial Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07124910 · 485 participants · Phase 3

    Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

  • NCT02871726 · 483 participants · NA

    Transrectal Ultrasound Robot-Assisted Prostate Biopsy

  • NCT06420531 · 486 participants · NA

    Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

  • NCT07097142 · 486 participants · Phase 3

    Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05421741, the US trial registry maintained by the National Library of Medicine. NCT05421741 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.